CTRI/2023/11/059780Not yet recruitingPhase 2
Phase II non randomized open clinical evaluation of siddha medicine maha analuruva chooranam for the management of uthiravatha suronitham (Rheumatoid arthritis) - Nil
Dr Dharani P0 sites0 target enrollmentStarted: TBDLast updated:
Trial Snapshot
- Phase
- Phase 2
- Status
- Not yet recruiting
- Sponsor
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
Inclusion Criteria
- •Age limit - 18 to 50 years
- •All genders
- •Morning stiffness more than 1 hour
- •Arthritis of more than 3 joints
- •Symmetrical arthritis
- •Patients positive for anti-CCP
Exclusion Criteria
- •Rheumatic fever
- •Psoriatic arthropathy
- •Gouty athritis
- •Any other serious systemic illness
- •Pregnant women and lactating mothers
- •Type 2 diabetes mellitus
- •The above criteria will be excluded clinically or based on the available medical reports.
Investigators
Similar Trials
Not yet recruiting
Phase 2
Seenthil Chooranam for Type II Diabetes MellitusCTRI/2023/08/056858J Rohini alias Elavarasi
Not yet recruiting
Phase 2
Clinical Evaluation of Siddha Medicine thuthuvelai chooranam for swasakasam (Bronchial asthma)CTRI/2023/11/060017M.Anitha
Not yet recruiting
Phase 2
Clinical evaluation of siddha medicine ajamodhastaga mathirai for Acid PEPTIC diseaseCTRI/2023/12/060462RJaya priya
Not yet recruiting
Phase 2
Clinical evaluation of Siddha medicine elathi chooranam for the management of hypertensioCTRI/2021/11/037810Government Siddha Medical College
Not yet recruiting
Phase 2
Clinical evaluation of siddha medicine Muppirandai chooranam for heavy menstrual bleeding.CTRI/2022/11/047297Dr R SHANTHINI
